French game developer. Life is Strange (original), Vampyr, Banishers: Ghosts of New Eden. Self-publishing + third-party.
The half‑year results for 2025 demonstrate a marked improvement in revenue and cost management, driven by the launch of Bloom & Rage and the completion of its integration into PS+. Total operating revenue rose to €13.9 million, a 5% decline from the first half of 2024 but reflecting a 3.8‑fold increase in core revenue to €7.0 million, offset by a €13.1 million write‑down of the Bloom & Rage asset that did not affect cash flow. Capitalized production fell by €5.9 million due to project completions and suspensions, partially counterbalanced by the development of P14.
Operating expenses were reduced through a Paris studio reorganisation and Canadian resource realignment, yielding €3.8 million in estimated savings for 2025 and a 16% year‑on‑year drop in personnel costs to €12.5 million. Operating EBITDA, including tax credits, moved closer to break‑even at –€2.0 million after excluding non‑recurring restructuring costs, and net loss narrowed to €20.8 million from €42.4 million a year earlier.
Cash flow improved, with negative free cash flow of €8.7 million (a €1.4 million improvement) and a closing cash balance of €23.4 million, while gross financial debt remained at €1.0 million. The Group’s strategy for the second half includes launching The Lonesome Guild, developing Aphelion for Xbox Game Pass, and advancing a co‑production of P14. A new development agreement with Netflix for a narrative game based on a major IP signals a strategic pivot toward cloud gaming and external licensing, reinforcing the company’s narrative‑centric identity.
Public limited company (Société Anonyme) with share capital of €168,018.74 Registered office: Parc du Pont de Flandre “Le Beauvaisis” 11 rue de Cambrai, 75019 Paris Paris Trade and Companies Register no. 504 161 902 MANAGEMENT REPORT ON THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2021 1.<sub>FIRST </sub>HALF 2021 HIGHLIGHTS In view of the exceptional circumstances surrounding the coronavirus (Covid-19) health crisis and the ensuing government recommendations, DONTNOD ...